blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4128269

EP4128269 - GENERATING CANCER DETECTION PANELS ACCORDING TO A PERFORMANCE METRIC [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  06.01.2023
Database last updated on 24.08.2024
FormerThe international publication has been made
Status updated on  29.10.2021
Formerunknown
Status updated on  19.05.2021
Most recent event   Tooltip26.07.2024Change - applicantpublished on 28.08.2024 [2024/35]
Applicant(s)For all designated states
Grail, Inc.
1525 O'Brien Drive
Menlo Park, California 94025 / US
[2024/35]
Former [2023/06]For all designated states
Grail, LLC
1525 O'Brien Drive
Menlo Park, CA 94025 / US
Inventor(s)01 / XIANG, Jing
Grail, Inc. 1525 O'brien Drive
Menlo Park, CA 94025 / US
02 / VALOUEV, Anton
Grail, Inc. 1525 O'brien Drive
Menlo Park, CA 94025 / US
 [2023/06]
Representative(s)Schröer, Gernot H.
Meissner Bolte Patentanwälte
Rechtsanwälte Partnerschaft mbB
Bankgasse 3
90402 Nürnberg / DE
[2023/06]
Application number, filing date21724883.020.04.2021
[2023/06]
WO2021US28035
Priority number, dateUS202063013512P21.04.2020         Original published format: US 202063013512 P
US20211723354819.04.2021         Original published format: US202117233548
[2023/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021216477
Date:28.10.2021
Language:EN
[2021/43]
Type: A1 Application with search report 
No.:EP4128269
Date:08.02.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 28.10.2021 takes the place of the publication of the European patent application.
[2023/06]
Search report(s)International search report - published on:EP28.10.2021
ClassificationIPC:G16H50/20, C12Q1/6886
[2023/06]
CPC:
G16H50/20 (EP); C12Q1/6886 (EP,US); C12Q1/708 (EP);
G16B20/00 (EP); G16B40/00 (US); C12Q2600/106 (US);
C12Q2600/118 (US); C12Q2600/156 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/06]
TitleGerman:ERZEUGUNG VON KREBSERKENNUNGSTAFELN NACH EINER LEISTUNGSMETRIK[2023/06]
English:GENERATING CANCER DETECTION PANELS ACCORDING TO A PERFORMANCE METRIC[2023/06]
French:GÉNÉRATION DE PANELS DE DÉPISTAGE DU CANCER EN FONCTION D'UN PARAMÈTRE DE PERFORMANCE[2023/06]
Entry into regional phase28.10.2022National basic fee paid 
28.10.2022Designation fee(s) paid 
28.10.2022Examination fee paid 
Examination procedure28.10.2022Examination requested  [2023/06]
28.10.2022Date on which the examining division has become responsible
19.05.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
14.03.2023Renewal fee patent year 03
13.03.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XYI]WO2018064547  (UNIV COLUMBIA [US]) [X] 1,3,4,6,7,11-13,15-20,22,23,48,49 * [005], [007]-[008], [0031], [0058], [0063]-[0069], [0073], [0084]-[0085], [0089], [0094]-[0095], [00100], [00104]-[00106];; figures 1, 4, 6-7, 16-18, 34-35; claim 1 * [Y] 1-23,48,49 [I] 2,5,8-10,14,21;
 [Y]WO2019055835  (UNIV CALIFORNIA [US]) [Y] 1-15* [0006]-[0008], [0031], [0034], [0037] *;
 [Y]WO2019200404  (GRAIL INC [US]) [Y] 1-23,48,49 * [0002]-[0003], [00167], [00188], [00551], [00566] *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.